CDH1 and cancer: Previous clinical studies also have revealed that the functional disruption of E-cadherin is associated with tumour dedifferentiation and metastasis in various human cancers including nonsmall cell lung cancers (NSCLCs) (Shibanuma et al, 1998; Sulzer et al, 1998; Liu et al, 2001).